APPLYING RISK ASSESSMENT FOR STERILE PHARMACEUTICAL PRODUCTS
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-FDP-006
- By: AKSU, Buket (Altınbaş University, Pharmaceutical Technology, Turkey)
- Co-author(s): Gizem Yeğen: Pharmaceutical Technology, Altınbaş University, ıstanbul, Turkey
Cansu Vatansever: Pharmaceutical Microbiology, Altınbaş University, ıstanbul, Turkey
Buket Aksu: Pharmaceutical Technology, Altınbaş University, ıstanbul, Turkey
BackgroundPharmaceutical compound are sensitive to contamination during manufacturing and also usage periods (1). Some medical products such as injections, ophthalmic preparations, dialysis solutions must be sterile for prevent the microbial degradation and infection development. Steril products must not contain any type of microorganisms (2).
Metho.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019